Based on the Immunoprecise Antibodies Ltd stock forecast from 0 analysts, the average analyst target price for Immunoprecise Antibodies Ltd is not available over the next 12 months. Immunoprecise Antibodies Ltd’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Immunoprecise Antibodies Ltd is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Immunoprecise Antibodies Ltd’s stock price was USD 0.41. Immunoprecise Antibodies Ltd’s stock price has changed by +6.75% over the past week, +6.78% over the past month and -66.85% over the last year.
No recent analyst target price found for Immunoprecise Antibodies Ltd
No recent average analyst rating found for Immunoprecise Antibodies Ltd
Company Overview Immunoprecise Antibodies Ltd
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving industry challenges. It provides NonaVac DNA for complex protein classes, including GPCRs and ion channels; and Rapid Prime, positive monoclonal antibodies for generating anti-idiotypic antibodies, and producing monoclonal antibodies against conformational epitopes. The company also offers syngeneic cell line for immunization and screening; peptide production for subsequent antibody discovery campaign; B cell select platform, which allows for the interrogation of animal antibody repertoire; screening of the immune repertoire of rabbits and chickens and desired antibody directly from the B cells; single step hybridoma, a semi-solid media to grow mouse and rat hybridomas; and DeepDisplay, a combination of transgenic animal platform and custom IPA phage display antibody selection. In addition, it provides phage display, a custom immune library; CAR development, an adaptable antibody, which allows the inclusion of functional data early in the screening funnel; antibody sequencing; and assay development. Further, it offers a profiling toolset for antibody lead candidates; and in vitro analytical tools for the study of quality attributes. Additionally, it provides LucinaTech, an antibody humanization to identify framework and CDR residues; antibody affinity maturation for therapeutic and diagnostic application; antibody chimerization for cloning and production of antibody domain; Eurofins preclinical services; hybrid service model designed to reduce time and risk with custom applications; breadth and depth to accelerate assay development, screening cascades, drug candidate validation, and new biotherapeutic concepts; and protein manufacturing services. The company was founded in 1983 and is headquartered Read Less
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and artificial intelligence through a series proprietary and patented technologies. The company owns an integrated end-to-end suite of capabilities to support the development of therapeut...Read More
Frequently Asked Questions About Immunoprecise Antibodies Ltd (IPA) Stock
Stock Target Advisor's fundamental analysis for Immunoprecise Antibodies Ltd's stock is Bearish.
Unfortunately we do not have enough data on IPA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on IPA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on IPA's stock to indicate if its overvalued.
The last closing price of IPA's stock was USD 0.41.
The most recent market capitalization for IPA is USD 0.02B.
Unfortunately we do not have enough analyst data on IPA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Immunoprecise Antibodies Ltd's stock.
As per our most recent records Immunoprecise Antibodies Ltd has 72 Employees.
Immunoprecise Antibodies Ltd's registered address is 823 Congress Ave, Austin, TX, United States, 78701.
You can get more information about it from Immunoprecise Antibodies Ltd's website at https://www.ipatherapeutics.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Immunoprecise Antibodies Ltd (IPA) Stock
Stock Target Advisor's fundamental analysis for Immunoprecise Antibodies Ltd's stock is Bearish.
Unfortunately we do not have enough data on IPA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on IPA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on IPA's stock to indicate if its overvalued.
The last closing price of IPA's stock was USD 0.41.
The most recent market capitalization for IPA is USD 0.02B.
Unfortunately we do not have enough analyst data on IPA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Immunoprecise Antibodies Ltd's stock.
As per our most recent records Immunoprecise Antibodies Ltd has 72 Employees.
Immunoprecise Antibodies Ltd's registered address is 823 Congress Ave, Austin, TX, United States, 78701.
You can get more information about it from Immunoprecise Antibodies Ltd's website at https://www.ipatherapeutics.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for IPA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
